Your browser doesn't support javascript.
loading
Identification of and solution for false D-dimer results.
Zhang, Xian-Yan; Zhang, Xue-Xuan; Xu, Jia-Long; Huang, Teng-Yi; Wu, Ying; Yang, Ye-Ru; Zhou, Huan-Bin; Wu, Ying-E.
Afiliação
  • Zhang XY; Department of Laboratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Zhang XX; Laboratory of Molecular Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Xu JL; Laboratory of Molecular Imaging, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Huang TY; Department of Laboratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Wu Y; Department of Laboratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Yang YR; Department of Laboratory Medicine, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Zhou HB; Department of Laboratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
  • Wu YE; Department of Laboratory Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.
J Clin Lab Anal ; 34(6): e23216, 2020 Jun.
Article em En | MEDLINE | ID: mdl-31967356
ABSTRACT

BACKGROUND:

Clinically, D-dimer (DD) levels are mainly used to exclude diseases such as deep venous thrombosis (DVT). In clinical testing, DD assays can be subjected to interference that may cause false results, which directly affect the clinical diagnosis. Our hypothesis was that the 95% confidence intervals (CIs) of the fibrin degradation product (FDP)/DD and fibrinogen (Fib)/DD ratios were used to identify these false results and corrected via multiple dilutions.

METHODS:

In total, 16 776 samples were divided into three groups according to the DD levels detected by Sysmex CS5100 and CA7000 Group A, DD ≥ 2.0 µg/mL fibrinogen equivalent unit (FEU); group B, 0.5 < DD < 2.0 µg/mL FEU; and group C, DD ≤ 0.5 µg/mL FEU. The 95% CIs of the FDP/DD and Fib/DD ratios were calculated. Six abnormal DD results were found according to the 95% CIs. For verification, we performed multiple dilutions, compared the results with those of other instruments, and tested the addition of heterophilic blocking reagent (HBR).

RESULTS:

The median and 95% CI of the FDP/DD ratio were 3.76 and 2.25-8.15 in group A, 5.63 and 2.86-10.58 in group B, 10.23 and 0.91-47.71 in groups C, respectively. For the Fib/DD ratio, the 95% CIs was 0.02-2.21 in group A, 0.68-8.15 in group B, and 3.82-55.27 in groups C. Six abnormal results were identified after multiple dilutions, by comparison with other detection systems, and after HBR addition.

CONCLUSIONS:

The FDP/DD ratio is more reliable for identifying false results. If the FDP/DD ratio falls outside the 95% CI, it should be verified by different methods.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos de Degradação da Fibrina e do Fibrinogênio / Imunoturbidimetria Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos de Degradação da Fibrina e do Fibrinogênio / Imunoturbidimetria Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged / Pregnancy Idioma: En Ano de publicação: 2020 Tipo de documento: Article